Synopsys, Inc. $SNPS Shares Sold by Dana Investment Advisors Inc.

Dana Investment Advisors Inc. lowered its holdings in shares of Synopsys, Inc. (NASDAQ:SNPS) by 96.8% during the third quarter, HoldingsChannel.com reports. The firm owned 1,460 shares of the semiconductor company’s stock after selling 44,375 shares during the period. Dana Investment Advisors Inc.’s holdings in Synopsys were worth $720,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds have also made changes to their positions in SNPS. Vanguard Group Inc. raised its stake in shares of Synopsys by 20.7% during the 3rd quarter. Vanguard Group Inc. now owns 18,181,185 shares of the semiconductor company’s stock worth $8,970,415,000 after buying an additional 3,120,401 shares during the period. Norges Bank purchased a new stake in Synopsys in the 2nd quarter worth $647,964,000. Ameriprise Financial Inc. raised its position in Synopsys by 29.1% during the second quarter. Ameriprise Financial Inc. now owns 2,598,874 shares of the semiconductor company’s stock worth $1,333,095,000 after acquiring an additional 585,494 shares during the period. M&G PLC lifted its holdings in Synopsys by 86,263.0% during the third quarter. M&G PLC now owns 567,405 shares of the semiconductor company’s stock valued at $279,731,000 after purchasing an additional 566,748 shares in the last quarter. Finally, Massachusetts Financial Services Co. MA grew its position in shares of Synopsys by 177.5% in the third quarter. Massachusetts Financial Services Co. MA now owns 865,987 shares of the semiconductor company’s stock valued at $427,269,000 after purchasing an additional 553,924 shares during the period. 85.47% of the stock is currently owned by hedge funds and other institutional investors.

Synopsys News Roundup

Here are the key news stories impacting Synopsys this week:

• Positive Sentiment: Q1 beat and big revenue upside — Synopsys reported non‑GAAP EPS $3.77 (above estimates) and revenue of $2.409B, up ~65% YoY, driven by Design Automation and the Ansys contribution; headline results support longer‑term AI chip‑design demand. Synopsys Posts Financial Results for First Quarter Fiscal Year 2026
• Positive Sentiment: Better FY26 EPS outlook — management set FY26 non‑GAAP EPS guidance ~14.38–14.46, well above consensus, suggesting management sees stronger full‑year earnings even if near‑term revenue cadence is choppy. Synopsys’ FY26 guidance likely conservative as analysts reiterate strong ratings
• Positive Sentiment: $2.0B buyback — the board authorized up to $2B of repurchases, a direct capital return that can support the stock and offset dilution from the Ansys deal. Synopsys Posts Financial Results for First Quarter Fiscal Year 2026
• Neutral Sentiment: Unusual options and whale activity — heavy call buying and large options volume were observed around the release, which can amplify intraday moves but may reflect short‑term, speculative positioning rather than conviction. Check Out What Whales Are Doing With SNPS
• Negative Sentiment: Mixed/softer near‑term guide and China risk — investors reacted to a Q2 revenue guide some saw as light and to commentary about China export restrictions that could mute near‑term growth in that region. Those factors pressured the stock despite the beat. Synopsys forecasts muted quarter on China export restrictions, shares fall
• Negative Sentiment: Acquisition costs, restructuring and debt concerns — reports note GAAP hit from Ansys integration, workforce reductions and the company’s elevated debt load from the transaction; these raise near‑term risk and make investors sensitive to guidance quality. Synopsys Stock (SNPS) Opinions on Earnings Release and AI Outlook
• Negative Sentiment: Analysts trim targets and neutrality rises — several firms cut price targets or lowered ratings after the print (Wells Fargo, Piper Sandler among them), which can add selling pressure even as many analysts remain constructive on AI exposure. Analyst price target and rating changes

Analyst Upgrades and Downgrades

A number of research analysts recently weighed in on the stock. Morgan Stanley reaffirmed an “overweight” rating on shares of Synopsys in a research note on Wednesday. The Goldman Sachs Group set a $600.00 target price on Synopsys and gave the company a “buy” rating in a research report on Wednesday. JPMorgan Chase & Co. boosted their price target on Synopsys from $600.00 to $650.00 and gave the stock an “overweight” rating in a research report on Thursday, December 11th. Weiss Ratings restated a “hold (c)” rating on shares of Synopsys in a report on Thursday, January 22nd. Finally, Wells Fargo & Company dropped their target price on shares of Synopsys from $500.00 to $450.00 and set an “equal weight” rating for the company in a report on Thursday. Nine investment analysts have rated the stock with a Buy rating, seven have issued a Hold rating and one has issued a Sell rating to the stock. According to MarketBeat, the company has an average rating of “Hold” and a consensus target price of $535.67.

Insider Buying and Selling

In other news, insider Janet Lee sold 250 shares of the company’s stock in a transaction on Monday, January 12th. The stock was sold at an average price of $530.00, for a total value of $132,500.00. Following the transaction, the insider owned 11,959 shares of the company’s stock, valued at $6,338,270. This represents a 2.05% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, CFO Shelagh Glaser sold 3,657 shares of the stock in a transaction on Friday, December 19th. The stock was sold at an average price of $460.77, for a total value of $1,685,035.89. Following the transaction, the chief financial officer owned 17,842 shares of the company’s stock, valued at approximately $8,221,058.34. This represents a 17.01% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Insiders sold 4,157 shares of company stock worth $1,945,036 over the last quarter. 0.62% of the stock is currently owned by insiders.

Synopsys Trading Down 5.2%

Shares of SNPS stock opened at $426.00 on Friday. The company has a current ratio of 1.62, a quick ratio of 1.52 and a debt-to-equity ratio of 0.48. Synopsys, Inc. has a twelve month low of $365.74 and a twelve month high of $651.73. The company’s 50-day moving average price is $472.21 and its 200-day moving average price is $478.66. The stock has a market cap of $81.60 billion, a price-to-earnings ratio of 66.15, a PEG ratio of 3.74 and a beta of 1.12.

Synopsys (NASDAQ:SNPS) last issued its earnings results on Wednesday, February 25th. The semiconductor company reported $3.77 EPS for the quarter, topping analysts’ consensus estimates of $3.56 by $0.21. Synopsys had a net margin of 13.76% and a return on equity of 7.49%. The company had revenue of $2.41 billion for the quarter, compared to the consensus estimate of $2.39 billion. During the same period in the previous year, the firm earned $3.03 earnings per share. Synopsys’s quarterly revenue was up 65.6% compared to the same quarter last year. Synopsys has set its FY 2026 guidance at 14.380-14.460 EPS and its Q2 2026 guidance at 3.110-3.170 EPS. As a group, equities analysts predict that Synopsys, Inc. will post 10.64 earnings per share for the current year.

About Synopsys

Synopsys, Inc is a leading provider of electronic design automation (EDA) software and semiconductor intellectual property (IP) used to design, verify and manufacture integrated circuits and complex systems-on-chip (SoCs). Its product portfolio spans tools and technologies for front‑end design and synthesis, simulation and verification, physical implementation and signoff, and design-for-manufacturability, enabling chip designers to move from architecture through tape‑out.

In addition to core EDA offerings, Synopsys supplies a broad set of semiconductor IP building blocks — such as interface, memory and analog/mixed-signal cores — that customers integrate into SoCs to accelerate development.